Brain Stimulation for PTSD

Recruiting at 1 trial location

Overseen By Jada Malveaux, MA

Age: 18 - 65

Sex: Any

Trial Phase: Academic

Sponsor: Florida State University

Must not be taking: Psychoactive medications, Calcium channel blockers

Disqualifiers: Major medical illness, Neurological disorder, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

Duration: Immediate pre- to post-stimulation

160 Participants Needed

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores a new method to help people with PTSD through brain stimulation. Researchers are testing whether Transcranial Alternating Current Stimulation (tACS) can calm the brain and reduce anxiety and hyper-alertness. Participants may receive tACS, another type of brain stimulation called Transcranial Random Noise Stimulation (tRNS), or a placebo. This study may suit individuals with PTSD who have been stable on medications for at least two months. As an unphased trial, it offers a unique opportunity to contribute to cutting-edge research that could lead to new PTSD treatments.

Will I have to stop taking my current medications?

If you are taking calcium channel blockers or alpha-blockers, you will need to stop these medications for 48 hours before the scan. For other medications, the protocol does not specify, but you should have medication stability for the past 2 months if you are taking psychotropic medications.

What prior data suggests that this brain stimulation technique is safe for treating PTSD?

Research has shown that Transcranial Alternating Current Stimulation (tACS) is safe and generally well-tolerated. Studies have found that tACS can reduce anxiety symptoms by using gentle electrical currents on the scalp to influence brain activity. For instance, one study suggested that using tACS at a specific frequency can lessen anxiety. Another study indicated that targeting certain brain patterns with tACS might also help with depression, which is linked to anxiety.

Similarly, Transcranial Random Noise Stimulation (tRNS), used as a comparison in some studies, is also considered safe. It uses random electrical currents to stimulate the brain and is non-invasive, meaning it doesn't involve surgery or entering the body.

Overall, both tACS and tRNS show promise in safely helping with mental health conditions. However, like any treatment, side effects can occur, so discussing participation in a clinical trial with a doctor is important. ^{1 2 3 4 5}

Why are researchers excited about this trial's treatments?

Researchers are excited about these treatments because they explore new ways of addressing PTSD symptoms through brain stimulation. Unlike traditional therapies such as cognitive-behavioral therapy (CBT) or medications like SSRIs, these treatments use electrical currents to directly influence brain activity. Transcranial Alternating Current Stimulation (tACS) targets brain waves at the alpha frequency, potentially enhancing relaxation and reducing hyperarousal associated with PTSD. Meanwhile, Transcranial Random Noise Stimulation (tRNS) introduces random electrical noise to the brain, which might help in resetting abnormal neural activity patterns. These innovative approaches open up possibilities for non-invasive, targeted interventions that could complement or offer alternatives to existing PTSD therapies.

What evidence suggests that this trial's treatments could be effective for PTSD?

Research has shown that transcranial alternating current stimulation (tACS) at alpha frequencies might help treat PTSD. This brain stimulation technique can enhance connectivity between different brain regions and reduce anxiety. One study found that 10 Hz-tACS effectively targets brain waves known as alpha oscillations, which are linked to relaxation and calmness. Another study suggested that similar treatments can significantly reduce PTSD symptoms. In this trial, participants will receive either alpha-frequency tACS or an active control treatment with transcranial random noise stimulation (tRNS). Overall, evidence supports the idea that alpha-frequency tACS could be a promising treatment for PTSD. ^{3 5 6 7 8}

Who Is on the Research Team?

Wen Li, PhD

Principal Investigator

The University of Texas Health Science Center, Houston

Are You a Good Fit for This Trial?

This trial is for right-handed individuals aged 18-50 with normal vision and smell, who meet specific safety criteria. Participants must have a PTSD diagnosis and if on psychotropic meds, they should be stable for the last 2 months. Substance users must abstain for 48 hours before the experiment.

Inclusion Criteria

Right-handed

If having mild substance use disorder (for patients) or occasional substance use, abstention from use 48 hours before the experiment.

Meeting the tACS screening criteria (e.g., lack of a serious head injury or loss of consciousness)

Exclusion Criteria

Regularly drinking 3 or more alcoholic beverages a day

Concurrent Axis I diagnosis (depression, anxiety, and mild substance use disorder are allowed given their high comorbidity with PTSD)

Severe psychiatric instability or severe situational life crises, including evidence of being actively suicidal or homicidal, or any behavior that poses an immediate danger to self or others

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive tACS or RNS stimulation and undergo EEG-fMRI recordings

Immediate pre- to post-stimulation

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

• alpha-frequency tACS
• Random noise stimulation

Trial Overview

The study tests a new theory of PTSD involving sensory cortex and amygdala-PFC dysfunctions by using two brain stimulation techniques: alpha-frequency tACS (transcranial alternating current stimulation) and random noise stimulation.

How Is the Trial Designed?

Group I: Transcranial Alternating Current Stimulation (tACS) Experimental Treatment 1 Intervention

Group II: Active Control - Transcranial Random Noise stimulation (tRNS) Active Control 1 Intervention

Group III: Sham for Transcranial Alternating Current Stimulation (tACS) Placebo Group 1 Intervention

Who Is Running the Clinical Trial?

Florida State University

Lead Sponsor

Trials

234

Recruited

41,100+

The University of Texas Health Science Center, Houston

Lead Sponsor

Trials

974

Recruited

361,000+

National Institute of Mental Health (NIMH)

Collaborator

Trials

3,007

Recruited

2,852,000+

Published Research Related to This Trial

In a study involving 22 healthy subjects, neither high-frequency nor low-frequency transcranial random noise stimulation (tRNS) produced significant changes in auditory steady state responses (ASSR) or resting state EEG activity, suggesting limited efficacy of tRNS in modulating these brain activities.

Interestingly, the sham tRNS condition led to a significant decrease in 20Hz ASSR and an increase in alpha frequency band activity, indicating that the act of stimulation itself, even without active tRNS, may influence brain activity.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Electrophysiological evaluation of high and low-frequency transcranial random noise stimulation over the auditory cortex. Schoisswohl, S., Langguth, B., Gebel, N., et al.[2021]

In a study with 15 healthy participants, both 1-mA and 2-mA transcranial direct current stimulation (tDCS) significantly increased motor cortical excitability, as measured by motor-evoked potentials, compared to baseline.

Transcranial random noise stimulation (tRNS) alone did not enhance cortical excitability, suggesting that the addition of a direct current offset is necessary for effective stimulation.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Comparison of the effects of transcranial random noise stimulation and transcranial direct current stimulation on motor cortical excitability. Ho, KA., Taylor, JL., Loo, CK.[2015]

Transcranial alternating current stimulation (tACS) significantly enhances gamma-band activity in response to auditory stimuli, improving both the magnitude and timing of these responses, while transcranial direct current stimulation (tDCS) does not have this effect.

Both tACS and tDCS strengthen the gamma phase connectome, which is important for synchronizing brain activity, suggesting that these noninvasive neurostimulation techniques can modify clinical biomarkers related to neurological and psychiatric disorders.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Modulation of auditory gamma-band responses using transcranial electrical stimulation. Jones, KT., Johnson, EL., Tauxe, ZS., et al.[2021]

Transcranial alternating current stimulation (tACS) is a promising non-invasive brain stimulation technique that can reset disturbed brain oscillations, potentially improving behavioral outcomes in psychiatric disorders, with initial studies showing no serious adverse events.

The review highlights that tACS may serve not only as a therapeutic tool but also as a diagnostic aid for psychiatric conditions, suggesting its dual role in both treatment and understanding of mental health issues.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Transcranial alternating current stimulation (tACS): from basic mechanisms towards first applications in psychiatry. Elyamany, O., Leicht, G., Herrmann, CS., et al.[2023]

Transcranial alternating current stimulation (tACS) at alpha frequency can induce lasting changes in brain oscillations, known as aftereffects, which are primarily explained by plasticity mechanisms rather than mere entrainment echoes.

In a study with 12 healthy participants, significant aftereffects were observed only with longer 8-second stimulation trains, suggesting that modifying brain oscillations with tACS could have potential clinical applications for conditions related to abnormal neural synchrony.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Alpha Power Increase After Transcranial Alternating Current Stimulation at Alpha Frequency (α-tACS) Reflects Plastic Changes Rather Than Entrainment. Vossen, A., Gross, J., Thut, G.[2022]

Transcranial alternating current stimulation (tACS) at alpha frequencies (8-12 Hz) applied over four days significantly enhanced long-range alpha connectivity in the brain, which lasted more than 24 hours after treatment, indicating potential for lasting neural changes.

This increase in connectivity was associated with reduced anxiety and improved perception of sensory stimuli, suggesting that tACS could be a promising intervention for psychiatric disorders linked to abnormal neural oscillations.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Lasting connectivity increase and anxiety reduction via transcranial alternating current stimulation. Clancy, KJ., Baisley, SK., Albizu, A., et al.[2019]

In a study involving 25 participants, it was found that decreasing the intensity of transcranial alternating current stimulation (tACS) from 1.0 mA to 0.4 mA switched the effect from excitation to inhibition of cortical excitability in the primary motor cortex.

The research demonstrated that different intensities of high-frequency transcranial electrical stimulation can selectively control the enhancement or reduction of motor cortex excitability, with 140 Hz tACS producing stronger inhibition than transcranial random noise (tRNS).

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Close to threshold transcranial electrical stimulation preferentially activates inhibitory networks before switching to excitation with higher intensities. Moliadze, V., Atalay, D., Antal, A., et al.[2016]

Transcranial random noise stimulation (tRNS) is a non-invasive method that can effectively modulate perception and enhance learning in individuals, indicating its potential as a therapeutic tool.

While tRNS shows promise for improving brain function, its effects on higher cognitive processes are inconsistent, suggesting that further research is needed to understand its long-term benefits and mechanisms of action.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Using noise for the better: The effects of transcranial random noise stimulation on the brain and behavior. van der Groen, O., Potok, W., Wenderoth, N., et al.[2022]

A survey of 152 service members and veterans revealed that cranial electrotherapy stimulation (CES) led to clinical improvements of 25% or more in anxiety (66.7%), PTSD (62.5%), insomnia (65.3%), and depression (53.9%).

Participants overwhelmingly perceived CES as safe (99.0%), and those not on prescription medications found it more effective than when combined with medication, highlighting CES as a promising noninvasive treatment option.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Military service member and veteran self reports of efficacy of cranial electrotherapy stimulation for anxiety, posttraumatic stress disorder, insomnia, and depression. Kirsch, DL., Price, LR., Nichols, F., et al.[2015]

Focal brain stimulation shows promise as a treatment for PTSD, with evidence suggesting that targeting specific brain areas involved in fear response and emotion regulation can enhance treatment efficacy.

Current research indicates that downregulating fear-related circuits (like the amygdala) and upregulating emotion regulation areas (like the prefrontal cortex) may be key to improving PTSD treatment outcomes, but more studies are needed to validate these targets and explore additional ones.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Defining focal brain stimulation targets for PTSD using neuroimaging. van Rooij, SJH., Sippel, LM., McDonald, WM., et al.[2022]

Transcranial alternating current stimulation (tACS) at 10 Hz effectively increased alpha power in the brain and improved general psychopathology symptoms, particularly depression, in patients with schizophrenia, as shown in a double-blind, randomized, placebo-controlled trial involving multiple sessions over a treatment week.

While tACS did not significantly reduce auditory hallucinations, the changes in brain connectivity correlated with symptom improvement, suggesting that tACS may have broader applications in treating mood-related symptoms across different mental health conditions.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Alpha transcranial alternating current stimulation reduces depressive symptoms in people with schizophrenia and auditory hallucinations: a double-blind, randomized pilot clinical trial. Zhang, M., Force, RB., Walker, C., et al.[2023]

Citations

1.

pmc.ncbi.nlm.nih.gov

pmc.ncbi.nlm.nih.gov/articles/PMC11224515/

A retrospective chart review to assess the impact of alpha ...

Additionally, rTMS delivered at IAF (α-rTMS) has been preliminarily reported to improve clinical response in PTSD (28). Symptom response to ...

2.

sciencedirect.com

sciencedirect.com/science/article/pii/S0001691825002525

Effectiveness of transcranial alternating current stimulation ...

This study investigates the impact of transcranial alternating current stimulation (tACS) at 10 Hz and individual alpha frequencies (IAF), along with cognitive ...

3.

nature.com

nature.com/articles/s41398-019-0439-0

Double-blind, randomized pilot clinical trial targeting alpha ...

Taken together, our results indicate that 10 Hz-tACS was effective in targeting alpha oscillations predominantly in the frontal and central ...

4.

cpn.or.kr

cpn.or.kr/journal/download_pdf.php?doi=10.9758/cpn.25.1298

The Therapeutic Effect of High-definition 1-Hz Transcranial ...

Conclusion: Preliminary findings suggest that HD-tACS in delta band can significantly alleviate PTSD symptoms, indicat- ing its potential as a ...

5.

withpower.com

withpower.com/trial/phase-stress-disorders-traumatic-3-2023-7dc2f

Brain Stimulation for PTSD

Research shows that alpha-frequency tACS can increase brain connectivity and reduce anxiety, which may help with PTSD. Additionally, a similar treatment, ...

6.

clinicaltrials.gov

clinicaltrials.gov/study/NCT05895006

A Neurosensory Account of Anxiety and Stress (Study 1)

This study will take a basic neuroscience approach to investigate pathological mechanisms underlying PTSD. Additionally, the study aims to identify how ...

7.

pmc.ncbi.nlm.nih.gov

pmc.ncbi.nlm.nih.gov/articles/PMC7867505/

Transcranial alternating current stimulation (tACS): from basic ...

tACS is a unique form of non-invasive brain stimulation. Sinusoidal alternating electric currents are delivered to the scalp to affect mostly cortical neurons.

8.

sciencedirect.com

sciencedirect.com/science/article/abs/pii/S0304394024002271

Neural consequences of 5-Hz transcranial alternating ...

Transcranial alternating current stimulation (tACS) at 5-Hz to the right hemisphere can effectively alleviate anxiety symptoms.